Pattreya Pokhagul

Ms. Pattreya Pokhagul is a senior professional pharmacist at the Health Product Vigilance Center, Strategy and Planning Division, and the Food and Drug Administration (FDA) of Thailand.

She holds a Bachelor of Pharmacy, Bachelor of Economics, and a Master of Pharmacy in Hospital and Clinical Pharmacy. She is a Board Member of the College of Pharmaceutical and Health Consumer Protection of Thailand and a Fellow of the Federation of Asian Pharmaceutical Associations College of Pharmacy.

Kyi Thar

Dr. Kyi Thar is a medical doctor, public health and pharmacovigilance expert. He has extensive working experience as a consultant for ADB over eight years in various health projects. Previously, he was a Technical Officer for surveillance and epidemiology at the WHO SEARO and the WHO DPR Korea. He was assigned as a Public Health Expert for UNOPS and Technical Director for the Malaria Consortium and Community Partners International. He also served as the Assistant Director for the Ministry of Health in Myanmar.

Adrien Inoubli

Dr. Adrien Inoubli has been Regional Adviser for Medical Products Regulation for 3 years in the WHO Regional Office for South-East Asia. In this position, he has been providing support to member states in strengthening their regulatory systems and has also acted as secretariat for SEARN, the South-East Asia Regulatory Network. Before joining WHO, he worked on regulatory processes, compassionate use, clinical trials, and marketing authorizations for the UK and French medicines agencies. His last position was representing France in the EMA’s pharmacovigilance committee, the PRAC.

SECURE Webinar 19: Enhancing the Quality and Safety of Medicine in Southeast Asia

COVID-19 posed a major challenge to the global health agenda, with pharmaceutical manufacturers shifting their production and distribution processes to rapidly respond to escalating demands for vaccines and medical products. The pandemic also revitalized the importance of sound pharmacovigilance (PV) systems and national regulatory authorities (NRA) to ensure the safety, quality, and efficacy of vaccines and drugs.